We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Rule 3 of the Pathology Services Table limits the benefits payable for pathology items during a single patient episode. Exemptions to this rule have been granted for certain specified tests in certain clinical circumstances. The exemption is referred to as ‘Rule 3 Exemption’.
Mater Pathology has produced the following user-friendly guide to tests covered by the Rule 3 Exemption to assist practitioners in its appropriate application in Out Patients.
In these instances, the request form must be endorsed ‘Rule 3 Exemption’ for the request to be valid. This request is then valid for the earlier of six months or the test frequency limit.
Anticoagulant (Warfarin) therapy
Cancer patients receiving Bisphosphate infusions
1. Request the pathology test in the normal way with the usual request form.
2. Specify the number of and frequency of the test.
3. Clearly endorse the form by writing ‘Rule 3 Exemption’.
4. Tests not listed as eligible for Rule 3 Exemption should be requested on a separate request form.
Tests eligible for Rule 3 Exemption will be carried forward and performed on subsequent episodes.
The information in this guide has been derived from the Medicare Benefits Schedule, 1 May 2010 (Rule 4 (2), p 631).